Showing 5111-5120 of 6978 results for "".
- 3 Oral JAK Inhibitors for Vitiligo 'Running to the Finish Line'https://practicaldermatology.com/news/3-oral-jak-inhibitors-vitiligo-running-finish-line/2468487/Recent data supporting the use of topical ruxolitinib and oral Janus kinase (JAK) inhibitors for treating vitiligo were presented by Dr. Seemal Desai and Dr. Larry Eichenfield at the 44th Annual Fall Clinical Dermatology Conference. In the TRuE-V1 and TRuE-V2 studies, for all body regions
- ADORING 3: Tapinarof Cream Maintains AD Clearance for 80 Days Post-Treatmenthttps://practicaldermatology.com/news/adoring-3-tapinarof-cream-maintains-ad-clearance-80-days-post-treatment/2468482/Results from the ADORING 3 long-term extension study showed that VTAMA® (tapinarof) cream, 1% achieved complete skin clearance in atopic dermatitis (AD) patients as young as two years old, maintaining clear or nearly clear skin for an average of 80 days post-treatment. The 48-week study, p
- Study: Roflumilast cream 0.15% Significantly Reduces Itch, Improves Quality of Lifehttps://practicaldermatology.com/news/study-roflumilast-cream-015-significantly-reduces-itch-improves-quality-life/2468468/New data show that ZORYVE® (Roflumilast) cream 0.15% rapidly alleviates symptoms of atopic dermatitis (AD) and significantly improves patient-reported outcomes, including daily activity, sleep, and emotional well-being, according to Arcutis. The manufacturer announced in a pres
- LEO Pharma Announced CHE Awareness Campaignhttps://practicaldermatology.com/news/leo-pharma-announced-che-awareness-campaign/2468442/LEO Pharma Inc. has launched Talk to the Hand, a disease awareness campaign for healthcare providers that highlights the risk factors, symptoms, and physical and emotional impact of chronic hand eczema (CHE)—a debilitating skin condition for which there are currently no FDA approved treatments. <
- World Hair Transplant Repair Day Set for November 11https://practicaldermatology.com/news/world-hair-transplant-repair-day-set-november-11/2468428/The International Society of Hair Restoration Surgery (ISHRS) will host its annual “World Hair Transplant Repair Day” on November 11, part of the ISHRS’s Fight the FIGHT (an acronym for Fight the Fraudulent, Illicit, and Global Hair Transplants) global consumer awareness campaign designed to educ
- LEO Pharma Says Anzupgo Launch in Germany Is 'First of Many'https://practicaldermatology.com/news/leo-pharma-says-anzupgo-launch-germany-first-many/2468408/Delgocitinib cream was launched for the first time worldwide in Germany, under the name Anzupgo®, LEO Pharma said in a press release. The drug was approved in September by the European Commission (EC) for the treatment of adult patients with moderate-to-severe chronic hand eczema (CHE), fo
- Analysis: Higher Infection and Acne Risks with JAK Inhibitors in ADhttps://practicaldermatology.com/news/analysis-higher-infection-and-acne-risks-jak-inhibitors-ad/2468381/Researchers for a new analysis have provided a data and analytics framework for the evaluation of the safety of immune-modulating drugs (IMDs) in treating atopic dermatitis (AD). The study authors designed the system to generate timely, high-quality evidence using sequential propensity sco
- ISHRS to Host 32nd World Congress in Denver This Monthhttps://practicaldermatology.com/news/ishrs-host-32nd-world-congress-denver-month/2468370/From refinements in hair restoration surgical techniques to understanding the psychological and physiological aspects of hair loss, the latest research and concepts in hair growth and restoration will be presented by some of the world’s most renowned hair restoration experts when they convene in
- Avene Partners With Dermatology Influencer at Ulta Beautyhttps://practicaldermatology.com/news/avene-partners-dermatology-influencer-ulta-beauty/2468359/Avene has announced a new partnership to bridge the gap between dermatological education and daily skincare, according to a news release. The French skincare brand is partnering with renowned boar
- Study Links Radioactive Iodine Therapy to Increased Melanoma Riskhttps://practicaldermatology.com/news/study-links-radioactive-iodine-therapy-increased-melnoma-risk/2468325/A new study found elevated risk of melanoma and other nonkeratinocyte skin cancers in patients with primary thyroid cancer who received radioactive iodine therapy, particularly in the head and neck region. In the JAMA Network Open article “Development of Melanoma and Other Nonkeratinocyte